Evidence map›Paper›PMID 42707210›Full record

ArticleFrontiers in pharmacology2026

Acute docosahexaenoic acid administration reduces binge-like ethanol consumption and palatable substances in C57BL/6J mice.

Ainhoa Sánchez-Gil, Francisca Carvajal, Diana Cardona, Jose Manuel Lerma-Cabrera

Abstract read
In one paragraph

Article in Frontiers in pharmacology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors.

Ainhoa Sánchez-GilDepartment of Psychology, University of Almeria, Almeria, Spain.
Francisca CarvajalDepartment of Psychology, University of Almeria, Almeria, Spain.
Diana CardonaHealth Research Center, CEINSA, University of Almeria, Almeria, Spain.
Jose Manuel Lerma-CabreraDepartment of Psychology, University of Almeria, Almeria, Spain.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Introduction: Excessive alcohol consumption, particularly binge drinking, is associated with cognitive impairments, emotional dysregulation and an increased vulnerability to alcohol use disorders. Emerging evidence suggests that docosahexaenoic acid (DHA), an omega-3 polyunsaturated fatty acid, modulates neuroinflammatory processes and influences dopaminergic signaling involved in reward-related behaviors. However, its acute effect on binge-like consumption remains poorly understood. The present study investigated the effects of acute oral administration of DHA-rich fish oil on binge-like drinking of ethanol in male and female C57BL/6J mice, utilizing caloric and non-caloric reinforcers to evaluate behavioral specificity. Methods: Using the Drinking-in-the-Dark (DID) paradigm, voluntary intake of ethanol, sucrose and saccharin were evaluated following DHA administration. To control potential confounds, spontaneous locomotor activity and anxiety-like behavior were assessed. Results: Acute DHA administration significantly reduced binge-like consumption of ethanol in both sexes, with a parallel reduction observed in sucrose and saccharin intake. Importantly, DHA did not alter locomotor activity or anxiety-like behaviors. Conclusion: These findings suggest that DHA exerts a rapid and robust dampening effect on binge consumption of both ethanol and natural rewards, supporting a potential role of DHA in modulating reward-driven intake. Collectively, this study highlights DHA as a promising candidate modulator of neurobehavioral processes associated with excessive and non-homeostatic consumption.

Indexed as

binge-like drinkingDHAdrinking-in-the-darkethanolpalatable substances

Identifiers

PMID42707210
PMCPMC13546985

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.